Portal de Periódicos da CAPES

Artigo Produção Nacional Revisado por pares

BIBTEX RIS

Clinical and molecular epidemiology of neonatal leukemia in Brazil

2014; Taylor & Francis; Volume: 56; Issue: 4 Linguagem: Inglês

10.3109/10428194.2014.938327

1042-8194

Suellen Valadares Moura, Francianne Gomes Andrade, Isis Quezado Magalhães, Imaruí Costa, Denise Bousfield Silva, Maria Lydia d'Andréa, Vitória P. Pinheiro, Maria Lúcia M. Lee, Fernando de Almeida Werneck, Mariana Emerenciano, Maria S. Pombo‐de‐Oliveira,

Epigenetics and DNA Methylation

The clinical and molecular findings of 77 cases of neonatal leukemia (NL) and 380 of infant leukemia (IL) were selected to distinguish features between NL and IL. Somatic gene mutations associated with acute leukemia including FLT3, RAS and PTPN11 were revisited. There were 42 cases of congenital leukemia associated with Down syndrome (DS) and 39 of these cases presented features of acute myeloid leukemia (AML)-M7. Twenty-seven of the DS cases underwent spontaneous remission and were reclassified as a transient myeloproliferative disorder. GATA1 mutations were found in 70% of these cases. In non-DS, frequent abnormalities were MLL rearrangements, mainly MLL-AFF1 in acute lymphoblastic leukemia and MLL-MLLT3 in AML. The FLT3 mutation was not found, while RAS (n = 4) and PTPN11 (n = 2) mutations were identified and reported for the first time in NL. There was substantial evidence to support that somatic abnormalities occur in utero. Thus, congenital leukemia is a good model for understanding leukemogenesis.